Maynard Um
-
-
-
-
-
-
-
Athira Pharma, Inc. (ATHA) Misses Q3 EPS by 5c
-
-
-
-
-
-
-
Athira Pharma Inc. (ATHA) Reports Topline Results from Phase 2/3 LIFT-AD Trial of Fosgonimeton
-
-
-
445,696 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

